Storm Therapeutics
Cambridge
About Storm Therapeutics
Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $69.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2022)
- Website: stormtherapeutics.com
- Phone: +44 (0)1223 804174
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/storm-therapeutics-25247 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.